You searched for oncology - Page 2 of 42

News and Trends 8 Dec 2022

Laevoroc Oncology pushes for relapsed leukemia cure

Laevoroc Oncology, a privately-owned, Swiss oncology development company, has announced the publication of key preclinical data carried out at the University of California, Los Angeles (UCLA), which provides mechanistic insights…

December 8, 2022 - 2 minutesmins - By Jim Cornall

microbiome seres eligo flagship cancer evelo

News and Trends 17 Nov 2015

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

The Microbiome and Immuno-Oncology fields are hugely trendy in the Biotech Industry – and now a marriage between the two has finally occurred… The Microbiome field is still very new,…

November 17, 2015 - 3 minutesmins - By Dani Bancroft

Helen Tayton Martin Adaptimmune interview

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

…in line with the benefits they bring. Since the immuno-oncology boom started by checkpoint inhibitors and CAR-T cells, researchers worldwide have started developing new immuno-oncology approaches that could solve some…

September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

bristol myers squibb immunooncology cancer opdivo psioxus

News and Trends 1 Jul 2016

BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech

…lot of money is changing hands, PD-1 and PD-L1 is a very hype area of Immuno-Oncology, and having a leader like BMS (with their exhaustive resources in Oncology and industrial…

July 1, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Jan 2017

Merck expands its Oncology Pipeline beyond Checkpoint Inhibitors

Merck is diversifying its oncology portfolio with four new programs licensed from Vertex Pharmaceuticals, including multiple DNA damage and repair drugs. Merck has entered a licensing agreement with Boston-based Vertex…

January 11, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

C7XeJ78WkAEE Ic 1.jpg large e1490029653662

Interview 20 Mar 2017

Immuno-oncology is Overcrowded – Here is Where Startups Can Succeed

The unprecedented competition in the field represents a daunting challenge for companies trying to break in. A BIO-Europe Panel discussed remaining niches. BIO Europe’s panel on immuno-oncology was perhaps the…

March 20, 2017 - 3 minutesmins - By Evelyn Warner

win horizon centauri antibody avvinity cancer alphamer

News and Trends 2 Mar 2016

New Joint Venture to Shake Up Immuno-Oncology in the UK

Avvinity Therapeutics is the new child of two UK Biotechs: Horizon Discovery and Centauri. The goal? To create the ultimate immuno-oncology toolbox with€32M. Just created, Avvinity is a joint venture…

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 26 Aug 2022

Aktis Oncology raises millions in funding bringing total to $161M

Aktis Oncology announced yesterday (August 25) that it has raised a series A extension financing of $84 million bringing its total capital raised to date to $161 million. The Massachusetts-based…

August 26, 2022 - 2 minutesmins - By Liza Laws

News and Trends 11 Apr 2023

Sumitomo Pharma Oncology receives orphan drug designation for Ewing sarcoma treatment

…sarcoma,” said Patricia S. Andrews, chief executive officer and global head of oncology, Sumitomo Pharma Oncology, Inc. “We recognize the unmet need for novel treatments in this disease state and…

April 11, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Sep 2022

Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed

…research, we spoke with Nadim Ahmed, CEO of Cullinan Oncology. Cullinan Oncology is a biopharmaceutical company dedicated to creating new standards of care for patients with cancer. It finds the…

September 23, 2022 - 4 minutesmins - By Jim Cornall

OncoDNA Biosequence Moncodaneum Cancer Big Data

News and Trends 18 Oct 2017

Belgian Biotech Gathers Major Oncology Centers to Tackle Cancer with Big Data

…be collaborating with the Strasbourg University Hospital, France, and the Oncology Center of Bydgoszcz, Poland, in the advancement of precision medicine for cancer. The two centers, oncology leaders in their…

October 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

msd avelumab pdl1 immunooncology pfizer etinostat

News and Trends 5 Jan 2016

How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…

…target in Immuno-Oncology. Program-Death ligand 1 (PD-L1) is already a common target for mAbs in immuno-oncology. If expressed on the tumor cells, this enables the cancer to form ligands (attachments)…

January 5, 2016 - 3 minutesmins - By Dani Bancroft

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: oncology

Laevoroc Oncology pushes for relapsed leukemia cure

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

How To Break Into The Crowded Immuno-Oncology Space

BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech

Merck expands its Oncology Pipeline beyond Checkpoint Inhibitors

Immuno-oncology is Overcrowded – Here is Where Startups Can Succeed

New Joint Venture to Shake Up Immuno-Oncology in the UK

Aktis Oncology raises millions in funding bringing total to $161M

Sumitomo Pharma Oncology receives orphan drug designation for Ewing sarcoma treatment

Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed

Belgian Biotech Gathers Major Oncology Centers to Tackle Cancer with Big Data

How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!